BackTable / VI / Podcast / Episode #480
Venous Treatments: How Low Do You Go?
with Dr. Adam Raskin
Get caught up on the current best practices and guidelines in venous interventions. Dr. Adam Raskin covers this and more, with host Dr. Sabeen Dhand in this discussion of DVT and PE treatments. Dr. Raskin is an interventional cardiologist, medical director of Cardiac ICU, and Co-Director of the PERT program at Mercy Health in Cincinnati, Ohio.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, September 17). Ep. 480 – Venous Treatments: How Low Do You Go? [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Adam Raskin
Dr. Adam Raskin is an interventional cardiologist in Cincinatti, Ohio.
Dr. Sabeen Dhand
Dr. Sabeen Dhand is a practicing interventional radiologist with PIH Health in Los Angeles.
Synopsis
Dr. Raskin shares his comprehensive approach for treating patients with DVT and PE, highlighting recent advancements in thrombectomy systems, as well as underscoring the need for more randomized trials to further build on current venous disease treatment guidelines. The doctors also touch on the significance of accurate diagnostic tools and thorough follow-up to improve patient outcomes.
Timestamps
00:00 - Introduction
10:58 - Approaching DVT & PE Patients
19:04 - Thrombectomy Advancements
24:02 - Iliofemoral Interventions & Standard Practices
26:32 - Accessing Tibial Veins & Clearing Clots
38:59 - Follow-Up & Data Collection
41:09 - Future of Venous Interventions
Resources
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II
Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine:
https://www.jvsvenous.org/article/S2213-333X(23)00322-0/fulltext
Transcript Preview
The one thing I could say is I think that at least showed, which we all know, making something that was occlusive, less occlusive, patients did get better. The post-thrombotic syndrome rates, despite it weren't different, were lower, especially in someone who got a catheter-directed therapy. Just, in my opinion, the wrong therapy, but we're heading in the right direction for sure. Even those patients who got anticoagulation, their post-thrombotic syndrome rates were really high. That's so devastating. When people do superficial vein work and they see these legs, if I had these deep veins that are occluded, now they have venous insufficiency, and I can't ablate anything because they're living on a saphenous, I'm like, "I would have done anything to have seen you three years ago and been able to use, the right catheter to open up your deep veins, and then we wouldn't be here."
The Symphony Thrombectomy System is intended for the non-surgical removal of fresh, soft emboli and thrombi from blood vessels. Injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel, intended for use in the peripheral vasculature and it is not for use in the pulmonary vasculature. Rx only. Important Safety Information may be found at http://bit.ly/3pAaUlw.
Views expressed are those of the speakers and not necessarily those of the sponsor. Certain content in this podcast contains forward-looking statements and no assurance of future results should be relied upon. Brands and trademarks referenced herein are those of their respective owners or holders.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.